Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.190
-0.020 (-1.65%)
May 8, 2025, 4:00 PM EDT - Market closed
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $80.42 million as of May 8, 2025. Its market cap has decreased by -23.53% in one year.
Market Cap
80.42M
Enterprise Value
-131.58M
1-Year Change
-23.53%
Ranking
Category
Stock Price
1.19
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $80.42M, a decrease of -80.06%. That is a compound annual growth rate of -34.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 80.42M | -33.54% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.77B |
| Johnson & Johnson | 378.96B |
| UnitedHealth Group | 352.94B |
| AbbVie | 334.43B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 233.33B |
| Novartis AG | 220.92B |
| AstraZeneca | 217.30B |